Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75 Ligand LM11A-31.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics • Vol. 18, Issue 2 • 2021
Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.
Scientific reports • Vol. 10, Issue 1 • 2020
A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
Human molecular genetics • Vol. 25, Issue 22 • 2016
Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.
Neurotoxicology • Vol. 45 • 2014
